'Next Generation' cancer treatment ready for clinical trials
(Medical Xpress) -- A new class of anti-cancer drugs which control the growth and spread of cancers and do so with minimal side effects is being developed by researchers at the University of Sydney.
"These new agents attack a fundamental characteristic of cancer cells while leaving normal cells alone," said Professor Des Richardson, from the Bosch Institute in Sydney Medical School.
"They work by binding the iron in tumor cells, preventing them from growing. We believe they have the potential to be an effective new strategy, to be 'next generation' drugs, for a range of cancers including highly aggressive pancreatic cancer.
Because they do not act on non-cancerous cells these new agents dramatically reduce a range of distressing side effects familiar to people undergoing cancer treatments such as chemotherapy and radiotherapy.
Professor Richardson is the head of the Iron Metabolism and Chelation Program at the University and has been conducting research in this area since the early 1990s.
The latest research on the chelators is led by post-doctoral researcher and NHMRC Early Career Fellow, Dr. Zaklina Kovacevic.
In the Journal of Biological Chemistry, published today, the researchers outline how these new agents increase the levels of a molecule (NDRG1) which inhibits the spread of cancer, including prostate and colon cancers.
"Together with a recent article in the journal, Antioxidants and Redox Signaling, these studies advance our knowledge of cancer cell biology and how we can target specific molecules to stop cancer progressing," Dr. Kovacevic said.
Professor Richardson is currently in advanced discussions on a licensing deal with an American company for developing the compound to the stage of clinical trials.
"This will present a significant step forward in the fight against cancer and provide cancer sufferers new hope for a better outcome," Professor Richardson said.
"It is a difficult step to go from the often quoted bench to bedside, but it has been greatly helped by the Bosch Institute's Translational Grants program, and by an NHMRC Development Grant."
The Executive Director of the Bosch Institute, Professor Jonathan Stone stated: "For anyone who has been through, or cared for a cancer sufferer through, the purgatory of chemotherapy, the prospect of anti-cancer drugs which are broadly effective but with few side effects is immensely welcome."
Journal reference: Journal of Biological Chemistry
Provided by University of Sydney
- Match your treatment to your cancer Jun 30, 2011 | not rated yet | 0
- Silencing a deadly conversation in breast cancer Jun 02, 2011 | not rated yet | 0
- Novel drug combination offers therapeutic promise for hard-to-treat cancers Sep 12, 2011 | not rated yet | 0
- Mechanism of action behind novel cancer agents targeting tumor cell metabolism discovered Jul 26, 2011 | not rated yet | 0
- Cell discovery strengthens quest for cancer treatments Feb 13, 2012 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
Alcohol and acetaminophen
May 13, 2013 Edit: sorry for the typo in the title , can't edit I looked around on google quite a bit and it's very hard to find precise information on the...
Marie Curie's leukemia
May 13, 2013 Does anyone know what might be the cause of Marie Curie's cancer
- More from Physics Forums - Medical Sciences
More news stories
The use of a smartphone application significantly improves patients' preparation for a colonoscopy, according to new research presented today at Digestive Disease Week (DDW). The preparation process, which begins days in ...
Cancer 13 hours ago | not rated yet | 0
Research presented at Digestive Disease Week (DDW) explores new methods for managing digestive health through diet and lifestyle.
Cancer 13 hours ago | not rated yet | 1
A ground-breaking advance in colonoscopy technology signals the future of colorectal care, according to research presented today at Digestive Disease Week(DDW). Additional research focuses on optimizing the minimal withdrawal ...
Cancer May 18, 2013 | 5 / 5 (2) | 0
(HealthDay)—Concurrent use of two immune checkpoint antibodies—ipilimumab and nivolumab—may be effective for the treatment of advanced melanoma, according to a proof-of-principal study presented in ...
Cancer May 17, 2013 | not rated yet | 0
(HealthDay)—The risks of metastasis and death associated with cutaneous squamous cell carcinoma (CSCC) are low, but significant, and risk factors for poor outcome include tumor diameter, invasion beyond ...
Cancer May 17, 2013 | not rated yet | 0 |
Researchers at the University of Wisconsin have identified a potential new risk factor for obstructive sleep apnea: asthma. Using data from the National Institutes of Health (Heart, Lung, and Blood Institute)-funded Wisconsin ...
1 hour ago | not rated yet | 0 |
A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.
1 hour ago | not rated yet | 0 |
Gourmands and foodies everywhere have long recognized ginger as a great way to add a little peppery zing to both sweet and savory dishes; now, a study from researchers at Columbia University shows purified components of the ...
1 hour ago | not rated yet | 0
In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...
2 hours ago | 5 / 5 (1) | 0 |
Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...
2 hours ago | 5 / 5 (1) | 0 |
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.
6 hours ago | not rated yet | 0